ATrain Education

 

Continuing Education for Health Professionals

WV: Best Practices for Prescribing Controlled Substances and Preventing Drug Diversion, 3 units

Module 11

References

American Academy of Pain Medicine (AAPM). (2016). For the Primary Care Provider: When to Refer to a Pain Specialist—A Recommendations Statement from the American Academy of Pain Medicine. Retrieved 6/23/2018 from http://www.painmed.org/files/when-to-refer-a-pain-specialist.pdf.

American Society of Addiction Medicine (ASAM). (2015). National Practice Guideline in the Use of Medications for the Treatment of Addiction Involving Opioid Use. Retrieved 4/8/2017 from https://www.asam.org/docs/default-source/practice-support/guidelines-and-consensus-docs/asam-national-practice-guideline-supplement.pdf.

American Society of Addiction Medicine (ASAM). (2017). June 16, 2017 Letter to Chris Christie, Chair, President’s Commission on Combating Drug Addiction and the Opioid Crisis. Retrieved 4/20/18 from https://www.asam.org/docs/default-source/advocacy/letters-and-comments/asam-recommendations-6-16-17.pdf?sfvrsn=2#search=%22trends%20in%20pain%20management%22.

Blau M. (2017). STAT forecast: Opioids could kill nearly 500,000 Americans in the next decade. Special Report. June 27, 2017. Retrieved 6/16/2018 from https://www.statnews.com/2017/06/27/opioid-deaths-forecast/.

Butler SF, Budman SH, Fernandez KC, et al. (2007). Development and validation of the Current Opioid Misuse Measure. Pain 130(1­2):144–56. Epub 2007 May 9. Erratum in: Pain. 2009;142(1-2):169. Retrieved 6/24/2018 from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950245/.

Centre for Addiction and Mental Health (CAMH). (2011). Addiction Toolkit. What are the aberrant drug-related behaviours that may indicate addiction? Retrieved 11/16/2014 from https://knowledgex.camh.net/primary_care/toolkits/addiction_toolkit/opioid_toolkit/Pages/faq_behaviours_indicate_addiction.aspx.

Centers for Disease Control and Prevention (CDC). (2017a). Annual Surveillance Report of Drug-Related Risks and Outcomes—United States, 2017. Surveillance Special Report 1. CDC, USDHHS. Published August 31, 2017. Retrieved 4/14/2018 from https://www.cdc.gov/drugoverdose/pdf/pubs/2017-cdc-drug-surveillance-report.pdf.

Centers for Disease Control and Prevention (CDC). (2017b). Guideline for Prescribing Opioids for Chronic Pain. Fact Sheet. Retrieved 4/15/2018 from https://www.cdc.gov/drugoverdose/pdf/Guidelines_Factsheet-a.pdf.

Centers for Disease Control and Prevention (CDC). (2017c). Vital Signs, July 6, 2017. “Opioid Prescribing: Where you live matters.” Retrieved 6/16/2018 from https://www.cdc.gov/vitalsigns/pdf/2017-07-vitalsigns.pdf.

Compton PA, Wu SM, Schieffer B, et al. (2008, October). Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to Medication Agreement Non-Compliance. J Pain Symptom Manage. 36(4): 383–395. Retrieved 6/24/2018 from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630195/.

Controlled Substance Automated Prescription Program (CSAPP). (2018). West Virginia Board of Pharmacy. The CSMP is available on the new website. Retrieved 4/8/18 from https://www.csappwv.com/Account/Login.aspx?ReturnUrl=%2f.

Corsini E, Zacharoff KL. (2014, 2011). Definitions related to aberrant drug-related behavior: Is there correct terminology? Retrieved 4/20/18 from https://www.painedu.org/articles_timely.asp?ArticleNumber=58.

Council on Economic Advisers (CEA). (2017). The Underestimated Cost of the Opioid Crisis. Retrieved 4/15/2018 from https://www.whitehouse.gov/sites/whitehouse.gov/files/images/The%20Underestimated%20Cost%20of%20the%20Opioid%20Crisis.pdf.

Dixon DW. (2018). Opioid Abuse: Practice Essentials, Background, Pathophysiology. Retrieved 4/15/2018 from https://emedicine.medscape.com/article/287790-overview#showall.

Dowling LS, Gatchel RJ, Adams LL, et al. (2007 Sept-Oct). An evaluation of the predictive validity of the Pain Medication Questionnaire with a heterogeneous group of patients with chronic pain. J Opioid Manag. 3(5):257-66. Retrieved 6/24/2018 from http://www.ncbi.nlm.nih.gov/pubmed/18181380.

Federal Register. (2014). Schedules of Controlled Substances: Rescheduling of Hydrocodone Combination Products from Schedule III to Schedule II. Retrieved 12/5/2014 from https://www.federalregister.gov/articles/2014/08/22/2014-19922/schedules-of-controlled-substances-rescheduling-of-hydrocodone-combination-products-from-schedule.

Federation of State Medical Boards (FSMB). (2017). Guidelines for the Chronic Use of Opioid Analgesics. Retrieved July 23, 2018 from http://www.fsmb.org/globalassets/advocacy/news-releases/2017/fsmb-releases-updated-guidelines-for-chronic-use-of-opioid-analgesics.pdf.

Federation of State Medical Boards (FSMB). (2013). Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain. Retrieved 12/18/2014 from http://www.fsmb.org/Media/Default/PDF/FSMB/Advocacy/pain_policy_july2013.pdf.

Food and Drug Administration (FDA). (2014). Opioid Patient-Prescriber Agreement. Retrieved 4/20/2018 from http://www.fda.gov/downloads/Drugs/DrugSafety/SafeUseInitiative/UCM388151.pdf.

Food and Drug Administration (FDA). (2018). Disposal of Unused Medicines: What You Should Know. Last updated 06/13/2018. Retrieved 6/23/2018 from https://www.fda.gov/drugs/resourcesforyou/consumers/buyingusingmedicinesafely/ensuringsafeuseofmedicine/safedisposalofmedicines/ucm186187.htm.

Florence CS, Zhou C, Luo F, Xu L. (2016). The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Medical Care 54(10):901–906. Retrieved 4/14/2018 from https://journals.lww.com/lww-medicalcare/Abstract/2016/10000/The_Economic_Burden_of_Prescription_Opioid.2.aspx.

Glover S, Girion L. (2014, May 22). In the Los Angeles Times, “Counties sue narcotics makers, alleging ‘campaign of deception.’” Retrieved 12/2/2014 from http://www.latimes.com/local/la-me-rx-big-pharma-suit-20140522-story.html#page=1.

Gupta R, Mullins C. (2018, May/June). West Virginia Bureau for Public Health News. West Virginia Medical Journal.

Gupta R, Mullins C. (2018, Jan/Feb). West Virginia Bureau for Public Health News. West Virginia Medical Journal.

Hedegaard H, Warner M, Miniño AM. (2017). Drug Overdose Deaths in the United States 1999–2016. NCHS Data Brief, No. 294. Hyattsville, MD: National Center for Health Statistics. Retrieved 4/14/2018 from https://www.cdc.gov/nchs/products/databriefs/db294.htm.

Institute of Medicine (IOM). (2011). Statement on pain. Note: The IOM name was changed to the Academy of Medicine in 2015.

International Association for the Study of Pain (IASP). (2018). IASP Statement on Opioids. Retrieved July 23, 2018 from http://www.iasp-pain.org/Advocacy/Content.aspx?ItemNumber=7194.

International Association for the Study of Pain (IASP). (2012). IASP Taxonomy, from Classification of Chronic Pain, 2nd ed. Originally published in 1994 and updated in 2012. Edited by H. Merskey and N. Bogduk. Seattle: IASP Press. Retrieved 6/23/2018 from http://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1698&navItemNumber=576. International Association for the Study of Pain (IASP). (2018). IASP Statement on Opioids. Retrieved 6/23/2018 from https://www.iasp-pain.org/Advocacy/OpioidPositionStatement.

Joint Commission, The. (2018). Facts about Joint Commission Accreditation Standards for Health Care Organizations: Pain Assessment and Management. Retrieved 4/7/2018 from https://www.jointcommission.org/facts_about_joint_commission_accreditation_standards_for_health_care_organizations_pain_assessment_and_management/.

Katz J. (2017). Drug Deaths in America Are Rising Faster than Ever. The New York Times. January 5, 2017. Retrieved 4/14/2018 from https://www.nytimes.com/interactive/2017/06/05/upshot/opioid-epidemic-drug-overdose-deaths-are-rising-faster-than-ever.html.

Lopez G. (2018, May 15). The growing number of lawsuits against opioid companies, explained. Retrieved 6/23/2018 from https://www.vox.com/policy-and-politics/2017/6/7/15724054/opioid-epidemic-lawsuits-purdue-oxycontin.

Lopez G. (2017). How to stop the deadliest drug overdose crisis in American history. December 21, 2017. Retrieved 6/23/2018 from https://www.vox.com/science-and-health/2017/8/1/15746780/opioid-epidemic-end.

McDonald DC, Carlson KE. (2013). Estimating the prevalence of opioid diversion by “doctor shoppers” in the United States. PLOS ONE 8(7):e69241, 2013. Retrieved 11/26/2014.

National Center on Addiction and Substance Abuse (CASA). 2017. Who Develops Addiction? Retrieved 4/8/2018 from https://www.centeronaddiction.org/addiction/addiction-risk-factors.

National Council of State Boards of Nursing (NCSBN). (2014). What You Need to Know About Substance Use Disorder in Nursing. Retrieved 4/7/2018 from https://www.ncsbn.org/SUD_Brochure_2014.pdf.

National Council of State Boards of Nursing (NCSBN). (2011). Substance Use Disorder in Nursing: A Resource Manual and Guidelines for Alternative and Disciplinary Monitoring Programs. [Still a valid source. No update made yet.] Retrieved 4/18/2018 from https://www.ncsbn.org/SUDN_11.pdf.

National Institute on Drug Abuse (NIDA). (2018a). Misuse of Prescription Drugs. Retrieved 4/20/18 from https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/2609-misuse-of-prescription-drugs.pdf.

National Institute on Drug Abuse (NIDA). (2018b). Opioid Summaries by State: West Virginia. Retrieved 4/14/2018 from https://www.drugabuse.gov/drugs-abuse/opioids/opioid-summaries-by-state/west-virginia-opioid-summary.

National Institute on Drug Abuse (NIDA). (2018c). Health Effects Chart. Revised June 2018. Retrieved 6/23/2018 from https://www.drugabuse.gov/drugs-abuse/commonly-abused-drugs-charts#prescription-opioids.

National Institute on Drug Abuse (NIDA). (2018d). Understanding Drug Abuse and Addiction. Retrieved 6/23/2018 from https://www.drugabuse.gov/publications/drugfacts/understanding-drug-use-addiction.

National Institute on Drug Abuse (NIDA). (2016). What Science Tells Us About Opioid Abuse and Addiction. January 27, 2016. Presentation by Nora D. Volkow, M.D. to the Senate Judiciary Committee. Retrieved 6/23/2018 from https://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2018/what-science-tells-us-about-opioid-abuse-addiction.

National Institute on Drug Abuse (NIDA). No date. Aberrant Drug Taking Behaviors Information Sheet. Retrieved 4/15/2018 from https://www.drugabuse.gov/sites/default/files/files/AberrantDrugTakingBehaviors.pdf.

National Institutes of Health, National Center for Complementary and Integrative Health (NCCIH). (2018). Chronic Pain In Depth. NCCIH Pub No.: D456. Retrieved 4/13/2018 from https://nccih.nih.gov/health/pain/chronic.htm.

Physicians for Responsible Opioid Prescribing (PROP). (2014). Cautious, Evidence-based Opioid Prescribing. Retrieved 6/17/2018 from http://66.147.244.123/~supposs3/wp-content/uploads/2014/01/PROP_OpioidPrescribing.pdf.

Protenus, Inc. (2018). 2017 Annual Drug Diversion Digest: Year in Review. Retrieved 6/10/2018 from https://www.naddi.org/protenus-drug-diversion-digest-year-in-review-2017/.

Substance Abuse and Mental Health Services Administration (SAMHSA). (2018). TIP 63: Medications for Opioid Use Disorder: For Healthcare and Addiction Professionals, Policymakers, Patients, and Families. SMA18-5063FULLDOC. Retrieved 4/14/2018 from https://store.samhsa.gov/shin/content//SMA18-5063FULLDOC/SMA18-5063FULLDOC.pdf.

Substance Abuse and Mental Health Services Administration (SAMHSA). (2017a). Behavioral Health Barometer: West Virginia, Volume 4: Indicators as measured through the 2015 National Survey on Drug Use and Health, the National Survey of Substance Abuse Treatment Services, and the Uniform Reporting System. HHS Publication No. SMA–17–Baro–16–States–WV. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2017.

Substance Abuse and Mental Health Services Administration (SAMHSA). 2017b. Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved 4/8/2018 from https://www.samhsa.gov/data/.

Substance Abuse and Mental Health Services Administration (SAMHSA). 2017c. Prescription Drug Misuse and Abuse. Retrieved 4/8/2018 from https://www.samhsa.gov/topics/prescription-drug-misuse-abuse.

Substance Abuse and Mental Health Services Administration (SAMHSA). (2016a). Opioid Overdose Prevention Toolkit: Facts for Community Members, Five Essential Steps for First Responders, Information for Prescribers, Safety Advice for Patients & Family Members, Recovering From Opioid Overdose. HHS Publication No. (SMA) 16-4742. Rockville, MD: Substance Abuse and Mental Health Services Administration. Retrieved 4/13/2018 from https://store.samhsa.gov/shin/content//SMA16-4742/SMA16-4742.pdf.

Substance Abuse and Mental Health Services Administration (SAMHSA). 2016b. The CBHSQ Report. September 29, 2016. In RN Lipari, E Park-Lee E and VH Struther (Eds.), America’s Need for and Receipt of Substance Use Treatment in 2015. Retrieved 4/20/2018 from https://www.samhsa.gov/data/sites/default/files/report_2716/ShortReport-2716.html.

Substance Abuse and Mental Health Services Administration (SAMHSA), Center for the Application of Prevention Technologies (CAPT). (2018). Engaging People Who Use Drugs in Prevention Efforts: Strategies for Reducing Stigma. Retrieved 6/23/2018 from https://captcollaboration.edc.org/engaging-people-who-use-drugs-strategies-reducing-stigma/.

Substance Abuse and Mental Health Services Administration (SAMHSA). (2014). NSDUH. (2013). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD. Retrieved 4/20/2018 from http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf

Substance Abuse and Mental Health Services Administration (SAMHSA). (2013). Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. Retrieved 4/8/2018 from https://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/DAWN2k11ED.pdf.

Substance Abuse and Mental Health Services Administration (SAMHSA). (2013). The CBHSQ Report: A Day in the Life of American Adolescents: Substance Use Facts Update. Retrieved 11/13/2014 from http://www.samhsa.gov/data/sites/default/files/CBHSQ128_1/CBHSQ128/sr128-typical-day-adolescents-2013.htm.

U.S. Department of Health and Human Services (HHS), Centers for Medicare & and Medicaid Services (CMS). (2014). Partners in Integrity: What Is a Prescriber’s Role in Preventing the Diversion of Prescription Drugs? Retrieved 6/29/2018 from http://www.cms.gov/medicare-medicaid-coordination/fraud-prevention/medicaid-integrity-education/provider-education-toolkits/downloads/prescriber-role-drugdiversion.pdf.

U.S. Department of Justice, Drug Enforcement Administration (DEA). (2018a).Controlled Substances Schedules. Retrieved 4/20/2018 from https://www.deadiversion.usdoj.gov/schedules/.

U.S. Department of Justice, Drug Enforcement Administration (DEA). (2018b). October 2017 14th National Drug Take Back Day Collection Results. Retrieved 4/7/2018 from https://www.deadiversion.usdoj.gov/drug_disposal/takeback/.

U.S. Department of Justice, Drug Enforcement Administration (DEA). (2006). [There is no new edition.] Practitioner’s Manual: An Informational Outline of the Controlled Substances Act. DEA Office of Diversion Control. Retrieved 6/16/2018 from http://www.deadiversion.usdoj.gov/pubs/manuals/pract/pract_manual012508.pdf.

U.S. Department of Justice, Drug Enforcement Administration (DEA). (n.d.). A Pharmacist’s Guide to Prescription Fraud. Retrieved 6/16/2018 from https://www.deadiversion.usdoj.gov/pubs/brochures/pdfs/a_pharmacists_guide_to_prescription_fraud.pdf.

U.S. Attorney’s Office, Southern District of West Virginia. (2018, April). Stuart Encourages West Virginians to Participate in DEA’s National Prescription Drug Take-Back Day. Retrieved 6/23/18 from https://www.justice.gov/usao-sdwv/pr/stuart-encourages-west-virginians-participate-deas-national-prescription-drug-take-back.

U.S. Department of Health and Human Services (HHS), Centers for Medicare & and Medicaid Services (CMS). (2014). Partners in Integrity: What Is a Prescriber’s Role in Preventing the Diversion of Prescription Drugs? Retrieved 12/2/2014 from http://www.cms.gov/medicare-medicaid-coordination/fraud-prevention/medicaid-integrity-education/provider-education-toolkits/downloads/prescriber-role-drugdiversion.pdf.

Veterans Administration, Department of Defense (VA/DoD). (2017). Tapering and Discontinuing Opioids factsheet. VA/DoD Clinical Practice Guideline for the Management of Opioid Therapy for Chronic Pain. Retrieved 12/1/14 from https://www.qmo.amedd.army.mil/OT/OpioidTaperingBooklet_FINAL_508.pdf.

WebMD Substance Abuse and Addiction Health Center. (2017). Painkillers, Narcotic Abuse, and Addiction. Last reviewed 12/27/2017. Retrieved 6/23/2018 from https://www.webmd.com/mental-health/addiction/painkillers-and-addiction-narcotic-abuse#1-2.

Webster, LR. (n.d.). Opioid Risk Tool. Retrieved 6/24/2018 from http://www.painknowledge.org/physiciantools/ORT/ORT%20Patient%20Form.pdf.

West Virginia Department of Health and Human Resources (WV DHHR). (2018, April 11). DHHR Releases Neonatal Abstinence Syndrome Data for 2017. Retrieved 4/20/2018 from https://dhhr.wv.gov/News/2018/Pages/DHHR-Releases-Neonatal-Abstinence-Syndrome-Data-for-2017-.aspx.

West Virginia Board of Medicine (WVBM). (2017). Policy on the Chronic Use of Opioid Analgesics. Adopted by the VWBM from the April 2017 Model Policy Guide of the Federation of State Medical Boards of the United States, Inc. Retrieved 6/17/2018 from https://wvbom.wv.gov/Position_Statementsnew.asp.

West Virginia Bureau for Behavioral Health & Health Facilities (WVBHHF). (2013). West Virginia Behavioral Health Epidemiological Profile. Retrieved from 6/24/2018 at http://www.dhhr.wv.gov/bhhf/resources/Documents/2013_State_Profile.pdf.

West Virginia Department of Health and Human Resources Bureau for Public Health (WVBPH). (2017). West Virginia Drug Overdose Deaths Historical Review 2001–2015. Retrieved 6/24/2018 from http://dhhr.wv.gov/oeps/disease/ob/documents/opioid/wv-drug-overdoses-2001_2015.pdf.

West Virginia Department of Health and Human Resources (WVDHHR). (2018, June 7). DHHR Announces Implementation of New Opioid Prescribing Requirements. 6/7/2018. Retrieved 6/24/18 from https://dhhr.wv.gov/News/Pages/DHHR-Announces-Implementation-of-New-Opioid-Prescribing-Requirements.aspx.

West Virginia Legislature, SB437. (2012). Governor’s Substance Abuse Prevention Bill. Retrieved 11/13/2014 from http://www.legis.state.wv.us/bill_status/bills_text.cfm?billdoc=sb437%20sub3%20enr.htm&yr=2012&sesstype=RS&billtype=B&houseorig=S&i=437.

Wu SM, Compton P, Bolus R, et al. (2006). The addiction behaviors checklist: Validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J Pain Symptom Manage. 32(4):342–51. Retrieved 4/20/2018from http://www.emergingsolutionsinpain.com/images/pdf/reslib/Addiction_Behaviors_Checklist.pdf.

WVUToday. (2017, November 28). WVU chief economist: Opioid Crisis Has Cost West Virginia Nearly $1 billion. Retrieved 6/23/2018 from https://wvutoday.wvu.edu/stories/2017/11/28/wvu-chief-economist-opioid-crisis-has-cost-west-virginia-nearly-1-billion.

Yudko E, Lozhkina O, Fouts A. (1997, March). A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat. 32(2):189-98. Retrieved 4/20/2018 from http://www.ncbi.nlm.nih.gov/pubmed/17306727.

Zimmerman B. (2017, February 28). Becker’s Hospital Review. 7 Things to Know About the History of The Joint Commission Pain Standards. Retrieved 4/20/2018 from https://www.beckershospitalreview.com/opioids/7-things-to-know-about-the-history-of-the-joint-commission-pain-standards.html.

    Instructions
  • Online
  • Study the course, take the test, register and pay, print your certificate. Done!

  • Print Option
  • Click "Print Option" to print a hard copy with mail-in instructions.

  • Take the Test